CNBC Television published this video item, entitled “SVB Leerink’s Geoffrey Porges on the effectiveness of Covid-19 vaccines against variants” – below is their description.
After a recent study was released about the B.1.351 variant’s impact on the effectiveness of Covid-19 vaccines, Geoffrey Porges, Director of Therapeutics Research and Senior Biotechnology Analyst at SVB Leerink, joins Worldwide Exchange to discuss the implications.
CNBC Television YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.